ESS vs NVCT · P/E 31, rev $1.89B vs $304.5M cap
Essex Property Trust Inc (ESS) versus Nuvectis Pharma Inc (NVCT) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
NVCT does not have a complete income-statement cache yet.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. NVCT currently screens at market cap $304.5M.
Not investment advice. Open the ESS and NVCT stock pages for the full models.
Not investment advice.